Bausch Health Companies
BHC
$0.38 (-5.13%)
1D
1W
3M
1Y
5Y
ALL
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company develops, manufactures, and markets, primarily in the therapeutic areas of eye health, gastroenterology (GI), and dermatology, a range of branded, generic and branded generic pharmaceuticals, over the counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries. The Company operates through five segments: Bausch + Lomb, Salix, International, Solta Medical, and Diversified Products. The Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, Consumer, Surgical, and Ophthalmic Pharmaceuticals products. The Salix segment consists of sales in the United States of gastrointestinal (GI) products. The Solta Medical segment consists of global sales of Solta aesthetic medical devices.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 6 days ago • BHC
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares FallZacks Investment Research • 7 days ago • BHC
Bausch Health (BHC) Q1 Earnings and Revenues Miss EstimatesAccesswire • 7 days ago • BHC
Bausch Health Announces First Quarter 2024 ResultsZacks Investment Research • 9 days ago • BHC
All You Need to Know About Bausch (BHC) Rating Upgrade to BuyAccesswire • 27 days ago • BHC
Bausch Health to Announce First-Quarter 2024 Results on May 2Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.